[1]
Peng, N.-X., Liu, C.-X., Wang, X.-S., Zhang, Z.-J. and Liao, S.-C. 2015. Combination of axitinib and dasatinib for anti-cancer activities in two prostate cancer cell lines. Bangladesh Journal of Pharmacology. 11, 1 (Dec. 2015), 130–137. DOI:https://doi.org/10.3329/bjp.v11i1.24149.